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Mitochondrial encephalomyopathy, lactic acidosis, and recurrent stroke-like episodes
syndrome (MELAS) is a rare degenerative disease. Recent studies have shown that
resistant training (RT) can ameliorate muscular force in mitochondrial diseases. However,
the effects of RT in MELAS are unknown. The aim of this case report was to investigate
the effects of RT on skeletal muscle and mitochondrial function in a 21-years old patient
with MELAS. RT included 12 weeks of RT at 85% of 1 repetition maximum. Body
composition (DXA), in vivo mitochondrial respiration capacity (mVO2) utilizing Near-
infrared spectroscopy on the right plantar-flexor muscles, maximal voluntary torque
(MVC), electrically evoked resting twitch (EET) and maximal voluntary activation (VMA)
of the right leg extensors (LE) muscles were measured with the interpolated twitch
technique. The participant with MELAS exhibited a marked increase in body mass
(1.4 kg) and thigh muscle mass (0.3 kg). After the training period MVC (+5.5 Nm), EET
(+2.1 N·m) and VMA (+13.1%) were ameliorated. Data of mVO2 revealed negligible
changes in the end-exercise mVO2 (0.02 mM min−1), 1 mVO2 (0.09 mM min−1), while
there was a marked amelioration in the kinetics of mVO2 (τ mVO2; 170.2 s). This
is the first report of RT-induced ameliorations on skeletal muscle and mitochondrial
function in MELAS. This case study suggests a preserved plasticity in the skeletal
muscle of a patient with MELAS. RT appears to be an effective method to increase
skeletal muscle function, and this effect is mediated by both neuromuscular and
mitochondrial adaptations.
Keywords: MELAS, exercise, neuromuscular function, muscle respiratory capacity, resistance training
INTRODUCTION
Mitochondrial diseases caused by mitochondrial DNA mutations are rare pathologies causing
devastating physical and neural impairments (Matsumoto et al., 2005; Sproule and Kaufmann,
2008). Among these pathologies, mitochondrial encephalomyopathy, lactic acidosis, and recurrent
stroke-like episodes syndrome (MELAS) is a rare neurodegenerative disease affecting several
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organs, particularly the nervous system and skeletal muscles with
a population prevalence of 236/100000 (Matsumoto et al., 2005).
The symptoms of MELAS include muscle weakness, recurrent
headaches, loss of appetite, and seizures. Stroke-like episodes are
common, often precipitating muscle weakness, unconsciousness,
vision abnormalities and brain damage, mobility impairment,
and a loss of cognitive function (Thambisetty and Newman, 2004;
Henry et al., 2017). Patients with MELAS generally have a poor
prognosis, as effective therapies for MELAS have yet to be found
(Pfeffer et al., 2012).
Given the central role of mitochondria in energy metabolism,
patients with mitochondrial dysfunctions have severe exercise
intolerance (Tarnopolsky and Raha, 2005) and patients are
often advised to avoid exercise, which leads to a vicious-cycle
of deconditioning. Contrasting with these recommendations,
recent studies have shown that aerobic exercise is actually
feasible without adverse events, and even beneficial, with
the prospect that this type of intervention may prevent
physical deconditioning, and attenuate exercise intolerance and
fatigability in these patients (Taivassalo et al., 1996, 1998, 1999;
Siciliano et al., 2000). Other important achievements of the
exercise training in this population are the ameliorations of
whole-body aerobic capacity and muscle oxidative metabolism
(Taivassalo et al., 2001; Cejudo et al., 2005; Taivassalo and Haller,
2005; Jeppesen et al., 2006). It is important to note, that besides a
remarkable impairment of the aerobic metabolism, patients with
MELAS also presents severe skeletal muscle losses. This imply
that, perhaps, a training method that can induce both positive
changes of mitochondrial (Porter et al., 2015) and neuromuscular
function of skeletal muscle may provide large benefits in terms
of exercise capacity and quality of life. However, to date, the
research on this matter in patient with MELAS has mainly
focused on the effects of very light aerobic exercise (Sproule
and Kaufmann, 2008), and limited data are available on other
training approaches.
Yet, some studies have reported specific positive effects
of resistant training (RT) in patients with neurological and
skeletal muscle dysfunctions (Tollback et al., 1999; Voet et al.,
2013). Noticeably, the studies of Taivassalo et al., 1998, 1999,
2006 and Taivassalo and Haller (2004, 2005); and the recent
study of Murphy et al. (2008) reported a clear physiological
rationale for the utilization of RT in patients with mitochondrial
dysfunction. In this last promising study have been reported
improvements of muscle strength (15–25%), and ameliorations of
oxidative capacity, reflected by an increase of oxygen extraction
and changes in the percentage of COX deficient (Murphy
et al., 2008). However, the effects of RT on the neuromuscular
function and mitochondrial oxidative capacity in MELAS are
currently unknown.
This study sought to investigate the effects of RT on
skeletal muscle and mitochondrial function in a 21 years
old male patient with MELAS. Specifically, by studying the
muscles mass, neuromuscular function of locomotor-limb and
in vivo muscular respiratory capacity after 12 weeks of RT
we tested the following hypotheses: (1) After the training
period, the locomotor-limb function would be increased, (2)
this amelioration in muscle function could be explained,
perhaps at least in part, by the improvement of neuromuscular
and structural factors, and (3) in vivo muscle respiratory
capacity would be improved in the skeletal muscle tissue
recruited during the RT.
CASE PRESENTATION
Participant
The participant was a 21-years-old male patient with MELAS
characterized by cytochrome c oxidase dysfunction. At the time
of study, the participant suffered of severe mobility impairment
(wheelchair limited), loss of hearing, partial blindness and
dysphagia. Muscle weakness and asthenia were coupled with an
exacerbated fatigue. From a cardiovascular point of view the
heart function was reduced leading to the necessity to implant
a DDDR pacemaker. The participant’s clinical characteristics
were determined by qualified medical members of the research
team (Table 1). Before testing, the participant abstained from
physical rehabilitation for 48 h, caffeine for 12 h, and food
for 3 h, and was not taking any drugs known to impact the
response to the assessment procedures. This study was carried
out in accordance with the recommendations of the Declaration
of Helsinki. The protocol was approved by the Department of
Neuroscience Biomedicine and Movement Science (Prot 227).
Caregiver of the case gave written informed consent for the case
participation in the study and publication of this case report. In
order to better categorize the singular data of the participants
with MELAS, a group of eight healthy age- sex-matched subjects
served as control group (CTRL). All CTRL subjects gave written
informed consent. CTRL subjects were healthy recreationally
active men, demographic characteristics are reported in Table 1.
Experimental Overview
The participants visited the laboratory on three occasions
separated by 24 h. The first visit comprised body composition
TABLE 1 | Subject characteristics.
MELAS CTRL
PRE POST
Age (years) 21 21 22 ± 2
Digit Span 3 3
Memory of Prose
(Range 0–28)
Memory 4 Recall 8 Memory 4 Recall 8
Rey Auditory Verbal
Learning Test
(Range 0–75)
Memory 23/75
Recall 6/15
Memory 23/75
Recall 6/15
Clock Drawing Test
(Range 0–10)
0 0
Frontal Assessment
Battery (Range
0–18)
8 8
Data of the control participants (CTRL) are given as mean ± standard deviation.
MELAS, Mitochondrial encephalomyopathy, lactic acidosis, and recurrent stroke-
like episodes syndrome.
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testing (DXA), and the clinical assessments. At the second visit,
the participants completed a familiarization with the interpolated
twitch and in vivo mitochondrial respiration capacity protocols.
At the third visit, the participants completed an in vivo
mitochondrial respiration capacity protocol utilizing a Near-
infrared spectroscopy device (NIRS) on the right plantar-flexor
muscles. After 60 min of recovery, maximal voluntary torque
(MVC), electrically evoked resting twitch (EET) and maximal
voluntary activation (VMA) of the right leg extensors (LE)
muscles were determiner with the interpolated twitch technique.
Only for the participant with MELAS these evaluations were
repeated after 12 weeks of RT.
Clinical Assessments
From a clinical point of view, the participant with MELAS
showed dysphagia to solids (he had a modified diet and
assumed food integrators). He presented with easy fatigability
and decreased muscle mass. No limitation of (main joints) range
of motion was found at the upper and lower limbs. Muscle tone
was not affected in a relevant way but needed some assistance to
change posture (from supine to sitting posture as well as from
sitting to standing posture).
The cognitive assessment battery utilized in this study was very
limited due to the severe hearing loss, vision acuity deficits and
hemianopia, in addition to the easy fatigue and eyelid ptosis. The
evaluation was focused on the main cognitive deficits reported in
the literature in the MELAS. The patient was perfectly oriented
in the space-time parameters, but with important deficits of
sustained and selective attention, with an easy distractibility.
The participant demonstrated deficits in short-term and long-
term verbal memory. The evaluation of executive functions
estimated with Frontal Assessment Battery and Clock Drawing
Test (Appollonio et al., 2005) revealed a lack of planning ability,
verbal ideation and inhibitory control. Tests’ scoring are reported
in Table 1.
Body Composition
Body composition (body fat and lean mass) was assessed by
means of Dual energy X-ray absorptiometry using a total body
scanner (QDR Explorer W, Hologic, MA, United States; fan-bean
technology, software for Windows XP version 12.6.1) according
to the manufacturer’s procedures. The scanner was calibrated
daily against the standard supplied by the manufacturer to
avoid possible baseline drift. Whole body scanning time was
about 7 min. Data were analyzed using standard body region
markers: upper and lower extremities, head, and trunk (pelvic
triangle plus chest or abdomen). Additionally, the DXA scans
were examined using non-standard body region markers to
define thigh segments. The thigh region was delineated by
an upper border formed by an oblique line passing through
the femoral neck to the horizontal line passing through the
knee (Skalsky et al., 2009). All scanning and analyses were
performed by the same operator to ensure consistency. In
our lab the precision error (percent coefficient of variation
with repositioning) of whole-body DXA measurements is
2.3, 0.5, and 2.8% for fat mass, lean mass and percent fat
mass, respectively.
In vivo Mitochondrial Respiration
Capacity
The assessment of in vivo mitochondrial respiration capacity
was performed via a non-invasive approach of the muscle
oxygen consumption (mVO2) as previously described by Ryan
et al. (2013, 2014a), Adami and Rossiter (2018). NIRS data
were obtained using a device (OxiplexTS, ISS, Champaign, IL,
United States), equipped with a standard acquisition probe
(emitter detector distances of 2.0, 2.5, 3.0, and 3.5 cm). The
values of oxygenated hemoglobin (Gonzalez-Alonso et al., 2001)
and deoxygenated hemoglobin [HHb] were recorded at 4 Hz
and expressed in micromoles using the Beer Lambert Law and
multi-distance frequency resolved spectroscopy.
The NIRS probe was positioned longitudinally on the belly
of the right plantar flexor muscles. The probe was secured with
double-sided adhesive tape and a Velcro strap around the calf.
After 30 min of warm-up period, the NIRS device was calibrated
using a phantom with known optical properties A blood pressure
cuff was placed proximal to the NIRS probe around the popliteal
area. The blood pressure cuff was controlled with a rapid-
inflation system (Hokanson E20, D.E. Hokanson) set to a
pressure of >250 mmHg and powered with an air compressor.
The NIRS experimental protocol consisted of two
measurements of resting mVO2 after the inflation of the
blood pressure cuff for 30 s. mVO2 was calculated as the rate of
change of the HHb signal during the arterial occlusion via linear
regression. Following the resting measurements, participants
performed a 30 s dynamic contractions of the plantar flexors
muscle to increase mVO2. Upon relaxation, the recovery kinetics
of mVO2 were measured using a series of transient arterial
occlusions with the following timing: 5 s on/5 s off for occlusions
1–5, 7 s on/7 s off for occlusions 6–10, and 10 s on/10 s off for
occlusions 11–20. Post-exercise mVO2 was calculated for each
occlusion using a linear regression. The mVO2 recovery kinetics
were determined by fitting the time-dependent changes during
the recovery period to a mono-exponential curve described by
the following equation:
Y(t) = Yend + Yamp(1− e−(t−TD/τ)) (1)
where Yend is the level of variable measured at end-of-exercise
and Yres refers to the amplitude of the response, TD represent
the time delay (TD), and τ reflects the time constant of the
recovery, a relative measure of muscle oxidative capacity (Adami
and Rossiter, 2018). Model variables were determined with an
iterative process by minimizing the sum of squared residuals
(RSS) between the fitted function and the observed values.
Goodness of fit was assessed by visual inspection of the residual
plot and the frequency plot distribution of the residuals, Chi
square values, and the coefficient of determination (r2), which
was calculated as follows:
r2 = 1− (SSreg/SStot) (2)
with SSreg, the sum of squares of the residuals from the fit and
SStot, and the sum of squares of the residuals from the mean.
Frontiers in Physiology | www.frontiersin.org 3 April 2019 | Volume 10 | Article 503
fphys-10-00503 April 25, 2019 Time: 16:15 # 4
Venturelli et al. Exercise Training in MELAS
Neuromuscular Function of
Locomotor-Limb
Maximal voluntary and electrically evoked muscle contractions
of the LE muscles were measured utilizing a custom-made
setup (Venturelli et al., 2015). Subjects were seated in an
upright position with back support. The hip and the knee
were flexed at 90◦, and the right ankle were attached, via a
strap and rigid steel bar, to a force transducer (DBBSE-100 kg,
A2829. Applied Measurements Limited, Aldermaston Berkshire,
United Kingdom). The output from the force transducer
was amplified (INT2-L, London Electronics Limited, Sandy
Bedfordshire, United Kingdom), and recorded at a sampling
rate of 5 KHz with a PowerLab-16/35 data acquisition system
(ADInstruments, Bella Vista, NSW, Australia).
Voluntary and EET Normalized Force
In the participant with MELAS the determination of muscle cross
sectional area via magnetic resonance imaging was not possible
due to the implanted pacemaker. Therefore, LE voluntary muscle
normalized force was calculated by dividing torque of the LE
isometric maximal voluntary contraction (MVC), by the lean
muscle mass of the corresponding muscles (nMVC) from DXA.
Similarly, EET normalized force was calculated by dividing
torque of the LE electrically evoked EET, by the lean muscle mass
of the corresponding muscle (nEET).
VoluntaryandEETnormalizedforce =
torque/thighleanmusclemass (3)
Electromyography
M-waves were recorded during femoral nerve stimulation
in the vastus lateralis muscle (detailed in next section).
Pairs of full-surface solid adhesive hydrogel electrodes (H59P,
Tyco Healthcare Group, Mansfield, MA, United States) were
positioned lengthwise over the muscle belly, with an inter-
electrode distance (center-to-center) of 20 mm. The ground
electrodes were fixed over the ipsilateral patella. Light skin
abrasion followed by skin cleansing kept electrical impedance
below 10 k. EMG signals were amplified with a pass-
band of 10 Hz–1 kHz and digitized online at a sampling
frequency of 5 kHz.
Nerve Stimulation
Each test procedure began with the determination of the maximal
M-wave and EET responses in the resting LE muscle. Briefly,
current intensity was progressively increased from 0 mA to the
value beyond which there was no further increase in M-wave
amplitude. The stimulus utilized for the study was set at the 125%
of the intensity required to produce a maximal M-wave response.
Electrical stimuli were delivered using circular (diameter 5.0 cm)
self-adhesive electrodes (Dermatrode, American Imex, Irvine,
CA, United States) positioned in the femoral triangle, 3–
5 cm below the inguinal ligament, and the anode placed over
the iliac crest. The EET were evoked in the passive muscle
using electrical stimulation consisting of single square-wave
pulses of 0.1-ms duration, delivered by a Digitimer DS7h
constant-current stimulator (Digitimer Ltd., Welwyn Garden
City, United Kingdom). The EET was measured 5 s after a
5 s MVC of the LE and this procedure was repeated six times.
Consequently, EET was assessed in the potentiated state. The
interval between the MVCs was 30 s. Peak torque, was assessed
for each EET (Sandiford et al., 2005). Voluntary activation of the
LE muscles during the MVCs was assessed using a superimposed
twitch technique (Merton, 1954). Briefly, the force produced
during a single twitch superimposed on the MVC was compared
with the force produced by the electrically evoked EET produced,
at rest, 5 s after the MVC.
Exercise Resistance Training
Resistant training included 60 min three times a week of high-
intensity strength training for an overall exercise duration of
12 weeks. Sessions started with 10 min of warm up which
included active joint mobilization of lower and upper limbs.
Then, the participant performed 3 sets of 10 reps of strength
exercises at 85% of 1 repetition maximum (1RM). 1RM was
determined by means of Brzycki method. Briefly, the participant
executed progressive series of the isotonic exercise until the
offered resistance was impossible to be sustained for 5/6
repetitions. The number of repetitions, and the relative workload,
were used in the Brzycki equation. 1RM was adjusted every
2 weeks and the corresponded training load was increased.
RT ended with stretching exercises for all the muscle involved
in the training. All training sessions were supervised by a
skilled kinesiologist.
Data Analysis and Interpretation
Control group data and muscle function values measured in the
participant with MELAS during six repetitions of isometric LE are
presented as mean ± standard deviation. Due to the descriptive
nature of this single case study any specific analysis was applied
to the collected data.
RESULTS
Characteristics of the Participants
One patient with MELAS and eight healthy controls were
successfully enrolled in the study. In Table 1 are displayed
demographic, clinical characteristics of the participants. The
patient with MELAS attended 31 (86%) of the 36 scheduled
sessions of RT and no adverse events occurred either during
exercise or the recovery phase of RT.
Muscle Mass and Function
As illustrated in Table 2 after 12 weeks of RT the participant with
MELAS exhibited a marked increase in body mass (1.4 kg) and
thigh muscle mass (0.3 kg) coupled with no detectable change in
body fat. Representative images of superimposed twitches evoked
in the participant with MELAS and a healthy control during the
MVCs of LE are displayed in Figure 1A. Representative EET
tracings in the LE muscle of the participant with MELAS and
a healthy control are displayed in Figure 1B. After the training
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period, the participant with MELAS exhibited an increase in
MVC (5.5 N·m), EET (2.1 N·m) and VMA (13.1%). Interestingly,
by normalizing MVC and EET for the thigh muscle mass all PRE
to POST differences were conserved (Table 2).
In vivo Muscular Mitochondrial
Respiration Capacity
Representative tracing of mVO2 kinetics in a healthy control and
the participant with MELAS are displayed in Figure 2, Panels
A and B, respectively. As illustrated in Table 2 after 12 weeks
of RT the participant with MELAS exhibited no detectable
changes in the end-exercise mVO2 (0.02 mM min−1), 1 mVO2
(0.09 mM min−1), while there was a marked amelioration in
the τ mVO2 (170.2 s).
DISCUSSION
Although RT has been shown to be feasible and likely
reduce some effects of skeletal muscle disuse in patients
with mitochondrial dysfunction, the effects of RT on the
neuromuscular and mitochondrial function in MELAS are not
established. In the present study we investigated the effects of RT
on skeletal muscle and mitochondrial function in a 21 years old
male patient with MELAS. In accordance with our hypothesis the
TABLE 2 | Effects of resistance training (RT) on body composition, muscle
function, in vivo and in vitro mitochondrial respiration capacity in a
subject with MELAS.
MELAS CTRL
PRE POST
Body composition
Body mass (kg) 36.2 37.6 70.7 ± 5.1
Body fat (%) 30.5 30.8 11.9 ± 2.5
Thigh muscle mass (kg) 2.11 2.21 6.85 ± 0.58
Muscle function during 6
repetitions of isometric
LE
MVC (Nm) 48.8 ± 4.4 54.3 ± 1.1 173 ± 15.4
EET (Nm) 11.6 ± 1.5 13.7 ± 0.9 41 ± 6.3
nMVC (Nm·kg−1) 23.1 ± 2.1 24.6 ± 0.5 25.2 ± 0.8
nEET (Nm·kg−1) 5.5 ± 0.7 6.2 ± 0.4 6.4 ± 0.5
VMA (%) 68.2 ± 7.9 81.3 ± 4.9 94.2 ± 3.1
In vivo mitochondrial
respiration capacity
End exercise mVO2
(mM·min−1)
1.99 2.01 9.82 ± 3.3
1 mVO2 (mM·min−1) 1.71 1.79 8.61 ± 2.5
τ mVO2 (s) 94.7 24.5 21.3 ± 3.2
Data of the control participants (CTRL) and muscle function values are given
as mean ± standard deviation. MELAS, Mitochondrial encephalomyopathy,
lactic acidosis, and recurrent stroke-like episodes syndrome; MVC, maximal
voluntary contraction; EET, electrical evoked twitch; nMVC, maximal voluntary
contraction normalized by thigh muscle mass; nEET, electrical evoked twitch
normalized by thigh muscle mass; VMA, voluntary activation; mVO2, muscle
oxygen consumption.
FIGURE 1 | Maximal voluntary contraction (MVC) and electrical evoked resting
twitch (EET) characteristics. (A) Presents example tracings of the
superimposed twitch technique utilized to determine muscle voluntary
activation in leg extensors (LE) in a patient with mitochondrial
encephalomyopathy, lactic acidosis, and recurrent stroke-like episodes
syndrome (MELAS). The superimposed twitches (arrows) were imposed at the
highest volitional steady-state torque. Representative examples of EET
torque-time curves from LE are illustrated in (B). MELASPRE and MELASPOST
represents force-tracing in a patient with MELAS before and after 12 weeks of
resistance training. Dashed line represent an example tracing of MVC (A) and
EET (B) of a healthy control (CTRL).
main findings of this study were: (1) After the training period
the locomotor-limb function was significant increased, exhibiting
strong ameliorations in MVC (5.5 N·m), EET (2.1 N·m) and
(2) These ameliorations in muscle function were coupled with
structural gains of muscle mass in the locomotor limbs (13%)
and a significant improvement of muscle recruitment, VMA
(13%). Interestingly, the in vivo muscular respiratory capacity
(τ mVO2) was also partially ameliorated after the RT. These
promising results suggest that RT is an effective exercise approach
in order to improve neurophysiological factors and muscles mass,
in patients with MELAS.
Structural, Neuromuscular and Muscle
Respiratory Capacity in MELAS
As expected, before the exercise training the muscle mass
of locomotor limbs was extremely reduced in the patient
with MELAS as indicated by the limited thigh muscle mass
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FIGURE 2 | In vivo mitochondrial respiration capacity. Panels (A,B) presents
examples of the oxidative capacity measured by NIRS in the plantar flexor of a
healthy 21-year-old male (CTRL) and a patient with MELAS before
(MELASPRE) and after (MELASPOST) 12 weeks of resistance training. The
mVO2 recovery data are fit to an exponential (continuous lines) to estimate the
recovery k. The time constant (τ) is the reciprocal of the rate constant k
(τ = 1/k).
(MELAS: 2.11 kg; CTRL: 6.85 ± 0.58). This limitation of
skeletal muscle mass was coupled with a severe reduction of
MVC (MELAS: 48.8 ± 4.4 Nm; CTRL: 173 ± 15.4 Nm),
and EET (MELAS: 11.6 ± 1.5 Nm; CTRL: 41 ± 6.3 Nm).
Moreover, maximal voluntary activation was severely reduced
(MELAS: 68.2 ± 7.9%; CTRL: 94.2 ± 3.1%). Overall these
results are comparable of those obtained in oldest-old and
mobility limited individuals (Venturelli et al., 2015, 2018),
suggesting that this reduction of muscle mass and force was
partially due to the direct effect of MELAS and the partial
disuse of the locomotor muscles. Moreover, muscle respiratory
capacity was substantially lower in the patient with MELAS
as indicated by the slower mVO2 time constant (MELAS:
94 s; Controls = 21.3 ± 3.2). In agreement with this result,
a twofold slower PCr recovery time constant measured by
31P Magnetic Resonance Spectroscopy has previously been
documented in a female patient suffering of MELAS compared
to controls (Szendroedi et al., 2009). Compared with other
studies examining muscle respiratory capacity in vivo in
various patients’ populations, the value reported here in this
individual with MELAS are also on the lower end of the
spectrum. For instance, faster Time Constant (∼30–60 s)
assessed by NIRS has been documented in the lower limb
muscle of patients with Cystic Fibrosis (Erickson et al.,
2015), Amyotrophic Lateral Sclerosis (Ryan et al., 2014b),
and Multiple Sclerosis (Harp et al., 2016). In fact, the value
observed here in our patient is similar to those reported
in individuals with Spinal Cord Injury [∼85 s, (Erickson
et al., 2017)], which due to the denervation of the muscle
exhibit an extreme level of deconditioning and severe muscle
atrophy. Together, these findings suggest severe functional
abnormalities of the skeletal muscle mitochondria, which
would explain the high susceptibility to the development
of type 2 diabetes in these patients (Velho et al., 1996;
Becker et al., 2002; Stark and Roden, 2007).
Neuromuscular and Structural
Effects of RT
Previously, Taivassalo et al., 1998, 1999, 2006 and Taivassalo
and Haller (2004, 2005) and lately Murphy et al. (2008)
reported a clear physiological rationale for the implementation
of RT in the standard rehabilitation program for patients
with mitochondrial dysfunctions. Specifically, these studies
revealed a significant increase in leg muscle strength following
RT (Murphy et al., 2008) and the results of the current
study are in agreement with these previous investigations.
Moreover, the present findings advance the knowledge on the
interactions between neuromuscular and structural adaptations
in response to RT in a rare pathology such the MELAS. The
data from the current investigation indicate that RT generated
positive effects on muscle structure and function. Specifically,
we observed an increase in both neuromuscular activation
and muscle mass of the limbs interested by the training
(Table 2 and Figure 1). Moreover, the nMVC, nEET, and
VMA indexes, suggests that after RT the gain of force was
primarily determined by ameliorations of the neuromuscular
function rather than hyper-trophy of the skeletal muscle. This
RT-induced amelioration in the neuromuscular function was
likely associated by changes in cortical function such as decrease
in inhibition and increased activity in many areas of the cerebral
cortex. Moreover, it is reasonable to assume that RT played a
significant role in the amelioration of voluntary force production
in the participant with MELAS likely due to greater intra and
intermuscular recruitment.
Effects of RT on Mitochondrial
Respiration
It is well established that RT increases skeletal muscle force
through the interplay of neuromuscular adaptations and the
increase in cross-sectional area of the muscle. However, recent
evidence suggest that mitochondrial adaptations can also occur
(Murphy et al., 2008). Specifically, Murphy et al. (2008) revealed
RT-related amelioration of VO2peak, coupled with decreased
in COX-deficient cells and increased COX activity, suggestive
of improved mitochondrial function within skeletal muscle
(Taivassalo et al., 2001; Taivassalo and Haller, 2004, 2005).
Interestingly, short-term RT has also been reported to increase
skeletal muscle respiratory capacity measured in vitro and in vivo
in young and older individuals (Jubrias et al., 2001; Pesta et al.,
2011). The results of the current study give further credence
to the hypothesis that RT can be a potent stimulus to induce
mitochondrial adaptations in healthy populations and patients
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with MELAS. As illustrated in Figure 2, the time constant
of mVO2 was drastically shortened from ∼94 s at baseline
to ∼25 s post training, i.e., a value similar to the control
group (∼21 s). Given the impairment in glucose control
and severe exercise intolerance associated with this disease,
these findings provide a proof of concept that RT represent
a safe and effective training method to induce metabolic
adaptations in the skeletal muscle of patients with MELAS. The
in vivo approach used herein to measure muscle respiratory
capacity with NIRS assess the integrated function of muscle
O2 transport and utilization. Therefore, while it is unlikely
that improvements in the convective or diffusive components
of O2 delivery occurred with this type of training, this
possibility cannot be entirely ruled out. Based upon previous
studies reporting both an increase in mitochondrial content
and function (Jubrias et al., 2001; Pesta et al., 2011), and
given the magnitude of the change in muscle respiratory
capacity observed here, it is likely that both structural and
functional changes contributed to this improvement. Further
studies using in vitro measurements of mitochondrial content
and respiratory function are therefore warranted to clarify the
exact mechanism contributing to this improvement in muscle
respiratory capacity in vivo. It is important to note, that
the muscle metabolic abnormalities observed in the patient
with MELAS are likely due to the disuse of locomotor limbs
but also primarily affected by an intrinsic metabolic problem
related to MELAS, and unfortunately partially corrigible with
increased physical activity. This result is partially in contrast
with previous investigation reporting the disappearance of
neuromuscular (Gruet et al., 2016) or metabolic (Decorte
et al., 2017) abnormalities in physically active patients with
cystic fibrosis.
CONCLUSION
To conclude, this study suggests a preserved plasticity in the
skeletal muscle of a patient with MELAS. More importantly,
Resistance Training appears to be a safe and effective method to
increase skeletal muscle function in this patient population, and
this effect is mediated by both neuromuscular and mitochondrial
adaptations. However, particular attention and caution is needed
in the interpretation of the data of this single case study and
further studies are warranted including larger sample of patients.
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